- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Overweight/Obese Population in Ireland
Total 130 results
-
Orexigen Therapeutics, IncCompleted
-
Orexigen Therapeutics, IncCompletedObesity | OverweightUnited States
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, United Kingdom, Canada, Denmark, Finland, Serbia, Poland, Japan, South Africa, Ireland
-
Novo Nordisk A/SRecruitingObesity | OverweightBrazil, United States, Argentina, Australia, Canada, Denmark, Germany, Greece, Italy, Japan, Latvia, Malaysia, Netherlands, Norway, South Africa, Sweden, Taiwan, Thailand, United Kingdom, Algeria, Croatia, Finland, India, Ireland
-
ShionogiCompleted
-
Rhythm Pharmaceuticals, Inc.Active, not recruitingGenetic ObesityUnited States, Spain, Netherlands, Germany, United Kingdom, Canada, Israel, Greece
-
Western University, CanadaCanadian Institutes of Health Research (CIHR); Public Health Agency of Canada...CompletedObesity | OverweightCanada, United States
-
Boehringer IngelheimRecruitingObesity | Non-alcoholic Fatty Liver DiseaseUnited States
-
Eli Lilly and CompanyRecruiting
-
ShionogiCompleted
-
Eli Lilly and CompanyRecruitingOverweight and ObesityUnited States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark
-
Rhythm Pharmaceuticals, Inc.RecruitingObesity | Genetic ObesityUnited States, Spain, Germany, Netherlands, United Kingdom, Greece, Puerto Rico, Canada, France, Israel
-
PfizerTerminatedObesityUnited States, Australia, Canada, Brazil, Slovakia, Czech Republic, Argentina, Germany, Mexico, United Kingdom, Sweden
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Orexigen Therapeutics, IncTerminated
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightUnited States, Taiwan, India, China, Japan, Mexico, Brazil, Puerto Rico, Argentina, Russian Federation
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Spain, United Kingdom, Thailand, India, Malaysia, Turkey, Mexico, Canada, Argentina, Germany, France, Poland, South Africa, Brazil, Bulgaria, Colombia, Denmark, Ireland, Japan
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
PfizerTerminatedObesity | Diabetes MellitusUnited States, Hungary, Canada, Japan, Poland, Puerto Rico, Bulgaria, Czechia
-
Novo Nordisk A/SActive, not recruitingObesity | Diabetes Mellitus, Type 2United States, Canada, Hungary, Portugal, Slovakia, South Africa, Poland, Bulgaria
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Poland, Israel, Italy, Mexico, Spain, Canada, Denmark, Finland, United Kingdom, France, Netherlands, Austria, Belgium, Argentina, Russian Federation, Serbia, Turkey, Switzerland, Germany, South Africa, Hungary, Hong Kong and more
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Type 2 DiabetesUnited States, China, Australia, India, Germany, Brazil, Greece, Argentina, Korea, Republic of, Czechia, Puerto Rico
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Czechia, Germany, Argentina, Greece, Slovakia
-
Eli Lilly and CompanyRecruitingObesity | Overweight | Obstructive Sleep Apnea | Type 2 DiabetesAustralia, United States, Mexico, Spain, India, Brazil, Romania, Taiwan, Argentina
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Hungary, Brazil, Slovakia